Quest Diagnostics (DGX) Depreciation & Amortization (CF): 2009-2025
Historic Depreciation & Amortization (CF) for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $142.0 million.
- Quest Diagnostics' Depreciation & Amortization (CF) rose 13.60% to $142.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $560.0 million, marking a year-over-year increase of 19.91%. This contributed to the annual value of $493.0 million for FY2024, which is 12.30% up from last year.
- Latest data reveals that Quest Diagnostics reported Depreciation & Amortization (CF) of $142.0 million as of Q3 2025, which was down 0.70% from $143.0 million recorded in Q2 2025.
- Over the past 5 years, Quest Diagnostics' Depreciation & Amortization (CF) peaked at $143.0 million during Q2 2025, and registered a low of $100.0 million during Q2 2021.
- For the 3-year period, Quest Diagnostics' Depreciation & Amortization (CF) averaged around $123.4 million, with its median value being $117.0 million (2024).
- As far as peak fluctuations go, Quest Diagnostics' Depreciation & Amortization (CF) declined by 6.03% in 2023, and later grew by 23.85% in 2024.
- Quest Diagnostics' Depreciation & Amortization (CF) (Quarterly) stood at $106.0 million in 2021, then increased by 9.43% to $116.0 million in 2022, then fell by 6.03% to $109.0 million in 2023, then rose by 23.85% to $135.0 million in 2024, then climbed by 13.60% to $142.0 million in 2025.
- Its Depreciation & Amortization (CF) was $142.0 million in Q3 2025, compared to $143.0 million in Q2 2025 and $140.0 million in Q1 2025.